Alcon
Swiss-American pharmaceutical and medical device company / From Wikipedia, the free encyclopedia
This article is about the medical company. For the surname, see Alcón. For other uses, see Alcon (disambiguation).
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people.[2]
Quick Facts Company type, Traded as ...
Company type | Public (Aktiengesellschaft) |
---|---|
Industry | Ophthalmology |
Founded | 1945; 79 years ago (1945) in Fort Worth, Texas, United States |
Headquarters | , United States |
Key people | David Endicott (CEO) |
Products | |
Revenue | US$9.46 billion (2023) |
US$1.04 billion (2023) | |
US$974 million (2023) | |
Total assets | US$29.6 billion (2023) |
Total equity | US$20.6 billion (2023) |
Number of employees | 25,315 (FTE, 2023) |
Website | alcon |
Footnotes / references [1] |
Close
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company.[3][4] Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies.[5]